Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
EPIDYS Study Group, Eugenio Mercuri, Juan J. Vilchez, Odile Boespflug-Tanguy, Craig M. Zaidman, Jean K. Mah, Nathalie Goemans, Wolfgang Müller-Felber, Erik H. Niks, Ulrike Schara-Schmidt, Enrico Bertini, Giacomo P. Comi, Katherine D. Mathews, Laurent Servais, Krista Vandenborne, Jessika Johannsen, Sonia Messina, Stefan Spinty, Laura McAdam, Kathryn SelbyBarry Byrne, Chamindra G. Laverty, Kevin Carroll, Giulia Zardi, Sara Cazzaniga, Nicoletta Coceani, Paolo Bettica, Craig M. McDonald
Dive into the research topics of 'Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial'. Together they form a unique fingerprint.